GNH USA

Europe — EMA

Olimestra (Olmesartan Medoxomil)

Olmesartan Medoxomil, the active ingredient in Olimestra, is an angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension in adults and helps reduce the risk of cardiovascular events.

Request sourcing

1
Pack/s

What is Olmesartan Medoxomil?

Olmesartan Medoxomil, the active ingredient in Olimestra, is an angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension in adults and helps reduce the risk of cardiovascular events. GNH USA supplies Olimestra as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olimestra as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Olmesartan Medoxomil used for?

Olimestra is an angiotensin II receptor blocker that lowers blood pressure by inhibiting the renin‑renin‑angiotensin‑aldosterone system.

- Hypertension: Lowers systolic and diastolic blood pressure in patients with primary essential hypertension. - Heart failure: Improves cardiac output  by   ...

What are the side effects of Olmesartan Medoxomil?

Common  ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Olmesartan Medoxomil
Route
Oral Use
Manufacturer
Krka, D.D., Novo Mesto
Origin
EU

Related products